Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gene Therapy for Human Sensorineural Hearing Loss
Yin Ren, Lukas D. Landegger, Konstantina M. Stanković
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

Deafness: from genetic architecture to gene therapy
Christine Petit, Crystel Bonnet, Saaïd Safieddine
Nature Reviews Genetics (2023) Vol. 24, Iss. 10, pp. 665-686
Open Access | Times Cited: 63
Disease mechanisms and gene therapy for Usher syndrome
Gwenaelle G.S. Géléoc, A. Amraoui
Hearing Research (2020) Vol. 394, pp. 107932-107932
Open Access | Times Cited: 70
Mini-PCDH15 gene therapy rescues hearing in a mouse model of Usher syndrome type 1F
Maryna V. Ivanchenko, Daniel M. Hathaway, Alex J. Klein, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 24
Choice of vector and surgical approach enables efficient cochlear gene transfer in nonhuman primate
Eva Andrés‐Mateos, Lukas D. Landegger, Carmen Unzu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
The genetic landscape and possible therapeutics of neurofibromatosis type 2
Mohammad Amin Ghalavand, Alimohamad Asghari, Mohammad Farhadi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 20
Gene Therapy for Neurofibromatosis Type 2-Related Schwannomatosis: Recent Progress, Challenges, and Future Directions
Ruofei Yuan, Bo Wang, Ying Wang, et al.
Oncology and Therapy (2024) Vol. 12, Iss. 2, pp. 257-276
Open Access | Times Cited: 6
New developments in neurofibromatosis type 2 and vestibular schwannoma
Yin Ren, Divya A. Chari, Saša Vasilijić, et al.
Neuro-Oncology Advances (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 46
A Critical Overview of Targeted Therapies for Vestibular Schwannoma
Ryota Tamura, Masahiro Toda
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5462-5462
Open Access | Times Cited: 27
Role of the Stria Vascularis in the Pathogenesis of Sensorineural Hearing Loss: A Narrative Review
Wenting Yu, Shimin Zong, Peiyu Du, et al.
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 29
Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy
Evan de Joya, Brett M. Colbert, Pei-Ciao Tang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3910-3910
Open Access | Times Cited: 27
Genetic etiology of hearing loss in Iran
Mojgan Babanejad, Maryam Beheshtian, Fereshteh Jamshidi, et al.
Human Genetics (2022) Vol. 141, Iss. 3-4, pp. 623-631
Closed Access | Times Cited: 19
Gene Therapy for Hearing Loss: Which Genes Next?
Ryan J. Carlson, Shahar Taiber, Jay T. Rubinstein
Otology & Neurotology (2025) Vol. 46, Iss. 3, pp. 239-247
Closed Access
Gene therapy and genome-editing for schwannoma in NF2-related schwannomatosis: current understanding and future directions
Ryota Tamura, Masahiro Yo, Masahiro Toda
Journal of Neuro-Oncology (2025)
Closed Access
Dual-AAV delivery of large gene sequences to the inner ear
Ellen Reisinger
Hearing Research (2019) Vol. 394, pp. 107857-107857
Open Access | Times Cited: 31
Advances in genome editing for genetic hearing loss
Ning Ding, Sangsin Lee, Matan Lieber-Kotz, et al.
Advanced Drug Delivery Reviews (2020) Vol. 168, pp. 118-133
Open Access | Times Cited: 31
Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss
Kamakshi Bankoti, Charles Generotti, Tiffany P. Hwa, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 21, pp. 209-236
Open Access | Times Cited: 26
Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss
Miodrag Stojković, Dongjun Han, Minjin Jeong, et al.
Stem Cells (2021) Vol. 39, Iss. 6, pp. 673-696
Open Access | Times Cited: 25
Pcolce2 overexpression promotes supporting cell reprogramming in the neonatal mouse cochlea
Changling Xu, Liyan Zhang, Yinyi Zhou, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 3
Nanoparticles for the Treatment of Inner Ear Infections
Dan Cristian Gheorghe, Adelina-Gabriela Niculescu, Alexandra Cătălina Bîrcă, et al.
Nanomaterials (2021) Vol. 11, Iss. 5, pp. 1311-1311
Open Access | Times Cited: 22
Anatomic, physiologic, and proteomic consequences of repeated microneedle-mediated perforations of the round window membrane
Stephen Leong, Aykut Aksit, Betsy Szeto, et al.
Hearing Research (2023) Vol. 432, pp. 108739-108739
Closed Access | Times Cited: 8
Technological socialities: The impact of information and communication technologies on belonging among deaf and hard‐of‐hearing people
Tanja Ahlin, Anja Hiddinga
Sociology Compass (2023) Vol. 17, Iss. 5
Open Access | Times Cited: 7
Lipid nanoparticles-encapsulated brain-derived neurotrophic factor mRNA delivered through the round window niche in the cochleae of guinea pigs
Toru Miwa, Haruki Saito, Hidetaka Akita
Experimental Brain Research (2020) Vol. 239, Iss. 2, pp. 425-433
Closed Access | Times Cited: 19
Directed differentiation and direct reprogramming: Applying stem cell technologies to hearing research
Marta Roccio
Stem Cells (2020) Vol. 39, Iss. 4, pp. 375-388
Open Access | Times Cited: 19
Therapeutic Application of Mesenchymal Stem Cells for Cochlear Regeneration
Nagarajan Maharajan, GWANG WON CHO, Chul Ho Jang
In Vivo (2021) Vol. 35, Iss. 1, pp. 13-22
Open Access | Times Cited: 16
Local Delivery of Therapeutics to the Cochlea Using Nanoparticles and Other Biomaterials
Shreshtha Dash, Jian Zuo, Peter S. Steyger
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1115-1115
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top